Nonalcoholic fatty liver disease (NAFLD) is a complex multisystem disease in which genetic
predisposition, obesity, visceral fat, insulin resistance, lipoprotein dysfunction, and gut …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with insulin
resistance and metabolic syndrome. The spectrum of disease ranges from simple steatosis …

Nonalcoholic fatty liver disease (NAFLD) is increasingly being diagnosed and is considered
to be the most frequent chronic liver disorder in Western countries. It represents a …

Non-alcoholic fatty liver disease (NAFLD) is a fatty liver disease associated with metabolic
dysfunction in genetically susceptible individuals due to over-nutrition and lack of exercise …

Non-alcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver
disease in the United States and worldwide. Increasing recognition of the importance of …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent cause of liver
disease worldwide, comprising a plethora of conditions, ranging from steatosis to end‐stage …

Non-alcoholic fatty liver disease (NAFLD) has emerged as a public health problem of
epidemic proportions worldwide. Accumulating clinical and epidemiological evidence …

Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver
diseases worldwide, causing considerable liver-related mortality and morbidity. During the …

Although accumulating evidence points to NAFLD emerging as a novel cardiovascular risk
factor, more research is needed to find suitable noninvasive biomarkers of NAFLD severity …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in
Western countries and can progress from simple steatosis to nonalcoholic steatohepatitis …